Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCIA for perioperative pain control during embolization of advanced malignant tumors
ChiCTR2100042421Phase 4Recruiting
- Sponsor
- Chengdu Qingbaijiang District People's Hospital
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in advanced nonhematological malignancy and perioperative pain (2 arms), sponsored by Chengdu Qingbaijiang District People's Hospital. Primary endpoint: Numerical Rating Scale (pain intensity). Started Jan 2021; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
advanced nonhematological malignancyperioperative pain
Beyond the preview
Go deeper on ChiCTR2100042421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042421.